- Suggested/Recommended/Usage/Directions
- Suggested Use: Take 8 capsules daily with food, in divided doses, or as directed by your healthcare professional. California residents should not exceed 4 capsules daily.
- Precautions re: Children
- Children and pregnant or lactating women should consult their healthcare professional prior to use.
- Precautions re: Pregnant or Nursing or Prescription Medications
- Children and pregnant or lactating women should consult their healthcare professional prior to use.
- Precautions re: All Other
- Do not use if tamper seal is damaged.
- Storage
- Storage: Keep closed in a cool, dry place out of reach by children.
- Precautions re: Children
- Storage: Keep closed in a cool, dry place out of reach by children.
- Formula re: Contains
- Optimal Multivitamin Plus includes a well-rounded blend of essential nutrients, along with superfoods, antioxidants, and specialized blends to optimize vision, liver, and cognitive function.
- FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- Formulation re: Does NOT Contain
- Does Not Contain: Milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soy, GMO, gluten, artificial colors, or artificial flavors.
- General Statements: All Other Content
- Optimal Multivitamin Plus Meets or Exceeds cGMP Quality Standards.
- Brand IP Statement(s) re: (c), (TM), (SM)
- Quatrefolic is a registered trademark of Gnosis S.p.A. Produced under US Patent 7,947,662.
DimaCal, Albion, and TRAACS are registered trademarks of Albion Laboratories, Inc.
Malates covered by U.S. Patent 6,706,904 and patents pending.
SelenoExcell is a registered trademark of Cypress Systems, Inc.
Truebroc produced under US patent 6,521,818 licensed from Brassica Protection Products LLC; truebroc is a trademark of Brassica Protection Products LLC.
BioPerine is a registered trademark of Sabinsa Corp. BioPerine is protected by US patents 5,536,506; 5,744,161; 5,972,382; and 6,054,585.